No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly males |
226754 |
2. Check conditionsNone |
226754 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
367 |
4. Check minimum number of eventsNone |
367 |
5. Include endpointsNone |
367 |
6. Filter based on genotype QC (FinnGen only) |
347 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Seminoma of testis, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of testis, including Hilmo
- Malignant neoplasm, wide definition for exclusion
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 347 | - | 347 |
| Unadjusted period prevalence (%) | 0.16 | - | 0.16 |
| Median age at first event (years) | 37.75 | - | 37.75 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 367
- Matched controls
- 3670
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
307.7
272
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
1058.3
304.7
258
8
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
276.2
229
*
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
962.5
237.2
208
5
JN4BD
NOMESCO Finland
Extensive body CT
37.4
220.0
152
68
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
19.0
117.4
103
74
A03FA01
ATC
metoclopramide; systemic, rectal
14.4
116.2
125
127
130
Kela drug reimbursment
Malignant tumour
+∞
113.6
103
*
JN4AD
NOMESCO Finland
Body CT examination
18.8
109.9
96
68
H02AB02
ATC
dexamethasone; systemic
50.3
88.5
52
12
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
83.6
77
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
71.2
66
*
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
52.4
49
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
51.3
48
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
50.2
47
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
547.0
49.6
48
*
A04AA01
ATC
ondansetron; systemic, rectal
21.5
48.2
37
19
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
45.8
43
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.8
44.2
79
142
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
40.4
38
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.0
37.7
217
976
WZC00
NOMESCO Finland
Treatment plan or consultation
4.0
36.4
165
628
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
35.0
33
*
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
35.0
33
*
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
35.0
33
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
+∞
35.0
33
*
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
369.7
34.5
34
*
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
33.9
32
*
JN3AD
NOMESCO Finland
Abdominal CT examination
5.4
33.0
75
167
121
Kela drug reimbursment
Severe hypofunction of sexual glands
37.2
31.6
40
12
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
30.6
29
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
28.5
27
*
L03AA02
ATC
filgrastim; parenteral
108.6
28.1
30
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
27.4
26
*
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
27.4
26
*
N02AA05
ATC
oxycodone; systemic
4.6
24.5
65
163
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.3
23.4
69
188
WF002
NOMESCO Finland
Radical radiotherapy
+∞
23.2
22
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
23.1
115
445
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.6
21.4
26
29
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.1
20.6
64
180
E29.1
ICD-10 Finland
Testicular hypofunction
7.1
20.4
32
49
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
77.6
19.9
22
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
210.9
19.8
20
*
XX3DW
NOMESCO Finland
Time consuming IT work
6.2
19.2
34
59
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
18.9
18
*
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
18.9
18
*
L01BC06
ATC
capecitabine; oral
+∞
17.9
17
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
100.0
17.7
19
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
188.7
17.7
18
*
ZXE00
NOMESCO Finland
One hour or less
2.6
16.1
140
711
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
15.7
15
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
15.7
15
*
N46
ICD-10 Finland
Male infertility
5.4
14.6
30
60
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
156.0
14.6
15
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
13.8
47
140
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
13.6
13
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
13.6
13
*
Y78
ICPC
Malign neopl male genital other
+∞
13.6
13
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
13.3
125
648
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
13.1
68
263
WX320
NOMESCO Finland
Spinalanesthesy
2.7
12.8
82
354
JN4CD
NOMESCO Finland
Very extensive body CT
16.2
12.8
20
13
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.6
12
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.6
12
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
12.6
12
*
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
12.6
12
*
L03AA13
ATC
pegfilgrastim; parenteral
134.4
12.5
13
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
11.9
125
675
WX402
NOMESCO Finland
General anaesthesia
2.6
11.6
78
344
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
11.5
11
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
11.5
11
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
11.5
11
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
11.5
11
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
36.3
11.3
14
*
D29.2
ICD-10 Finland
Benign neoplasm: Testis
36.3
11.3
14
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.5
11.2
22
42
Z51.5
ICD-10 Finland
Palliative care
9.7
11.2
22
24
WZC30
NOMESCO Finland
Teaching
2.8
10.6
57
224
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
10.5
10
*
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
10.5
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
10.5
10
*
ZX120
NOMESCO Finland
Intravenous
3.5
10.1
36
110
WW500
NOMESCO Finland
Blood transfusion
9.5
10.1
20
22
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
10.5
9.6
18
18
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
4.4
9.5
24
57
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
9.4
9
*
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
+∞
9.4
9
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
9.4
9
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
9.4
9
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.7
9.0
29
83
B01AB05
ATC
enoxaparin; parenteral
2.2
8.8
83
423
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.9
8.8
21
32
N02BE01
ATC
paracetamol; systemic, rectal
2.4
8.6
307
2514
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.3
8.6
17
19
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
28.3
8.5
11
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
92.1
8.4
9
*
7513
FHL
Test prosthesis installation
92.1
8.4
9
*
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
8.4
8
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
8.4
8
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
8.4
8
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.4
8
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.3
8.1
21
51
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
46.0
7.7
9
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
7.3
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
9061/3-C62.0
ICD-O-3
Seminoma, NOS, of undescended testis
+∞
7.3
7
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
16.1
7.3
11
7
B01AB10
ATC
tinzaparin; parenteral
3.3
7.0
26
82
R50.9
ICD-10 Finland
Fever, unspecified
2.3
7.0
58
279
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.8
7.0
15
20
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
6.7
59
290
KA1FN
NOMESCO Finland
Isotope renography
23.0
6.7
9
*
Y05
ICPC
Scrotum/testis sympt/compl other
7.1
6.6
15
22
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
71.0
6.4
7
*
N05BA06
ATC
lorazepam; systemic, sublingual
3.3
6.4
24
76
Y28
ICPC
Limited function/disability (Y)
11.3
6.3
11
10
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
9063/3-C62.9
ICD-O-3
Spermatocytic seminoma of testis, NOS
+∞
6.3
6
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
1860A
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOPL MAL TESTIS (ABDOMIN/INGUIN),SEMINOMA]
+∞
6.3
6
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
6.3
6
*
JN4DG
NOMESCO Finland
Body very extensive MRI with high intensity magnet
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
C62.09
ICD-10 Finland
Malignant tumor of the non-descending testicle, other or undetermined histology
+∞
6.3
6
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
6.3
6
*
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
6.3
6
*
116
Kela drug reimbursment
Prostate cancer
+∞
6.3
6
*
KFB00
NOMESCO Finland
Biopsy of testis
27.2
6.3
8
*
N02AA01
ATC
morphine; systemic, rectal
12.8
6.1
10
8
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
6.1
62
323
J01MA12
ATC
levofloxacin; systemic
2.2
6.1
57
288
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
185
29
127.62
307.65
7.8
2.4
85.49
2.84
u/ml
0.50
177
29
200
8
540.75
221.96
8.8
1.1
16.39
—
u/l
—
56
0
78
34
28.86
110.80
3.6
1.4
16.65
6.91
iu/l
3.48
69
24
105
106
13.47
97.06
3.1
1.5
7.31
3.98
u/l
3.60
93
92
95
6
212.63
95.34
9.4
1.0
—
—
—
0
0
301
1934
4.09
26.08
12.0
5.8
76.43
74.19
u/l
0.59
296
1831
239
1418
2.97
21.86
11.9
7.5
3.63
4.25
e9/l
5.49
215
1260
39
69
6.21
21.65
1.5
3.2
3.84
3.91
g/l
0.07
39
69
44
95
5.13
19.72
6.3
1.9
4.14
2.52
ug/l
1.26
36
77
134
628
2.79
18.59
5.5
2.0
2.36
2.35
mmol/l
0.60
125
552
128
591
2.79
18.22
3.6
2.6
0.61
0.28
e6/l
0.40
102
452
137
660
2.72
17.90
3.8
2.7
98.25
137.84
e6/l
0.13
108
517
83
323
3.03
15.98
5.9
1.8
2.43
2.42
mmol/l
0.64
74
270
151
799
2.51
15.90
3.9
2.8
—
—
—
0
0
166
930
2.43
15.29
2.8
2.3
—
—
—
0
0
87
356
2.89
15.25
3.3
2.4
1.13
1.14
e6/l
0.01
57
202
84
340
2.91
15.00
3.6
2.5
0.40
0.49
e6/l
0.23
54
185
218
1462
2.21
12.20
5.7
5.0
6.74
6.89
mmol/l
0.35
207
1379
156
958
2.09
10.51
9.3
4.4
36.59
36.83
g/l
0.21
145
888
164
1034
2.06
10.22
12.0
6.7
1.20
1.20
mmol/l
0.01
131
909
183
1238
1.95
9.01
6.8
6.2
26.57
28.05
%
1.09
175
1185
49
198
2.70
8.57
2.5
1.9
208.16
243.44
pmol/l
1.26
49
190
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
63
4.01
8.38
4.1
3.4
0.26
0.29
u/ml
0.29
12
35
145
935
1.91
7.99
10.3
6.4
1.21
1.20
mmol/l
0.48
140
865
315
2641
2.36
7.82
19.5
9.4
86.75
88.49
ml/min/173m2
0.60
285
2161
177
1230
1.85
7.63
6.6
6.0
58.86
56.79
%
1.62
168
1181
155
1063
1.79
6.75
16.6
13.9
1.40
1.31
inr
0.36
40
313
89
525
1.92
6.20
1.8
1.7
1.28
0.97
mg/l
0.46
70
374
46
212
2.34
6.09
3.4
2.7
—
—
—
0
0
321
2814
2.12
5.51
21.7
12.5
139.39
139.74
mmol/l
2.15
314
2740
59
318
2.02
5.29
12.0
7.8
103.64
104.30
mmol/l
0.58
59
318
17
49
3.59
5.24
1.6
1.4
285.38
334.72
ug/g
—
8
28
321
2831
2.07
5.15
22.0
12.6
4.02
4.01
mmol/l
0.32
313
2758
79
476
1.84
5.08
3.2
2.1
—
—
—
0
0
153
1116
1.64
4.92
3.3
2.9
0.03
0.00
estimate
0.39
32
208
317
2795
1.98
4.92
19.7
10.7
23.38
23.46
mg/l
0.01
261
2129
154
1126
1.63
4.90
3.3
2.9
0.00
0.00
estimate
-0.00
30
177
152
1110
1.63
4.85
5.1
4.0
0.00
0.00
estimate
-0.00
31
200
15
43
3.59
4.66
2.5
3.6
56.20
54.26
%
0.37
15
43
24
93
2.69
4.57
1.3
1.7
228.75
261.56
mu/l
0.43
24
87
30
132
2.39
4.42
1.7
1.5
—
—
—
0
0
12
24
5.13
4.35
1.2
1.1
—
—
—
0
0
56
322
1.87
4.15
4.3
2.4
12.57
14.38
umol/l
1.06
51
301
14
42
3.43
4.08
2.6
3.6
3.64
4.03
e9/l
0.34
14
42
7
8
8.89
3.79
3.7
1.1
176.00
168.88
u/l
—
7
8
191
1535
1.51
3.70
3.9
3.2
1.73
1.60
ug/l
0.35
170
1395
276
2406
1.59
3.62
25.4
12.7
14.39
16.12
%
0.44
271
2364
26
118
2.30
3.60
2.4
1.5
—
—
—
0
0
98
685
1.59
3.57
3.6
2.3
364.46
8200.82
umol/l
3.00
93
622
7
9
7.90
3.57
1.3
2.7
—
—
—
0
0
12
32
3.84
3.42
2.7
1.5
—
—
—
0
0
335
3101
1.92
3.18
14.4
8.0
32.18
33.85
u/l
0.90
330
3012
28
140
2.08
3.10
1.8
1.4
—
—
—
0
0
121
913
1.49
3.05
3.3
2.9
—
—
—
0
0
42
244
1.81
3.03
6.5
3.2
1.01
1.63
mmol/l
0.58
36
206
42
245
1.81
2.99
6.5
3.2
5.86
5.85
kpa
0.01
42
238
5
5
10.11
2.98
1.2
1.2
12.60
11.68
u/l
—
5
5
47
284
1.75
2.98
4.8
2.5
24.58
25.47
%
0.19
41
245
55
348
1.68
2.96
2.9
1.7
—
—
—
0
0
40
235
1.79
2.79
4.2
2.4
27.91
241.72
u/l
0.54
34
203
17
72
2.43
2.77
1.1
1.1
—
—
—
0
0
44
267
1.74
2.75
4.4
2.6
8.95
10.68
umol/l
0.22
37
237
12
44
2.79
2.57
2.7
1.6
—
—
—
0
0
12
44
2.79
2.57
2.7
1.6
—
—
—
0
0
16
71
2.31
2.38
1.1
1.2
325.09
279.77
u/ml
0.26
11
47
11
40
2.80
2.29
1.5
1.6
—
—
—
0
0
102
791
1.40
2.13
3.3
2.6
54.34
64.54
u/l
0.93
93
753
5
10
5.05
2.07
1.2
1.4
4.66
2.63
mg/l
—
5
10
7
20
3.55
2.06
2.0
1.8
—
—
—
0
0
7
20
3.55
2.06
1.3
1.5
0.16
0.17
nmol/l
—
7
15
19
97
2.01
2.04
2.7
2.7
4.74
4.71
pmol/l
0.03
14
86
15
70
2.19
2.01
3.6
1.5
—
—
—
0
0
24
134
1.85
2.00
1.5
1.4
—
—
—
0
0
7
22
3.22
1.89
3.4
1.4
—
—
—
0
0
248
2704
0.74
1.85
4.3
3.8
6.02
6.02
mmol/l
0.02
225
2502
8
29
2.80
1.80
1.4
1.4
—
—
—
0
0
272
2920
0.74
1.76
4.1
4.0
1.27
1.28
mmol/l
0.09
254
2761
6
18
3.37
1.75
4.8
1.9
—
—
—
0
0
8
30
2.70
1.73
3.4
1.6
—
—
—
0
0
8
30
2.70
1.73
3.4
1.6
—
—
—
0
0
81
625
1.38
1.73
2.9
3.1
1003.24
1229.64
ng/l
0.36
69
511
277
2963
0.73
1.72
4.4
4.3
2.86
2.85
mmol/l
0.04
262
2792
11
48
2.33
1.72
1.5
1.5
—
—
—
0
0
7
25
2.83
1.65
3.4
1.4
—
—
—
0
0
205
1816
1.29
1.64
3.9
3.6
12.72
8.97
mm/h
2.05
188
1700
344
3300
1.68
1.62
31.1
15.1
41.44
42.82
%
3.69
328
3095
5
14
3.61
1.62
1.4
1.1
—
—
—
0
0
5
14
3.61
1.62
1.4
1.1
—
—
—
0
0
5
14
3.61
1.62
1.4
1.1
—
—
—
0
0
5
14
3.61
1.62
1.4
1.1
—
—
—
0
0
5
14
3.61
1.62
1.4
1.1
—
—
—
0
0
344
3301
1.67
1.60
30.3
15.0
231.54
238.99
e9/l
1.68
339
3224
119
984
1.31
1.60
3.4
3.2
70.90
55.41
ng/l
0.17
83
644
7
26
2.72
1.59
1.0
1.5
—
—
—
0
0
13
64
2.07
1.56
2.4
1.5
—
—
—
0
0
344
3306
1.65
1.53
30.4
14.9
4.69
4.82
e12/l
4.55
338
3220
62
471
1.38
1.46
2.5
2.1
2.92
2.92
mg/l
0.00
53
401
275
2927
0.76
1.45
4.1
4.0
4.68
4.62
mmol/l
0.34
258
2775
29
190
1.57
1.42
2.6
2.0
66.93
68.49
ml/min/173m2
0.05
15
68
30
199
1.55
1.40
6.2
2.5
5.91
4.61
kpa
1.70
30
192
5
17
2.97
1.36
3.6
1.2
—
—
—
0
0
5
17
2.97
1.36
3.6
1.2
—
—
—
0
0
5
17
2.97
1.36
3.6
1.2
—
—
—
0
0
36
252
1.48
1.32
2.8
1.7
—
—
—
0
0
9
43
2.12
1.31
1.8
1.3
—
—
—
0
0
9
43
2.12
1.31
1.8
1.3
—
—
—
0
0
9
43
2.12
1.31
1.1
1.2
—
—
—
0
0
6
24
2.52
1.31
1.0
1.1
—
—
—
0
0
49
367
1.39
1.26
1.9
1.8
1009.56
1177.96
nmol/l
0.80
35
302
25
370
0.65
1.26
1.2
1.2
12.42
26.35
iu/ml
—
9
112
6
25
2.42
1.25
3.7
2.4
506.83
723.76
e6/l
—
6
25
36
257
1.44
1.21
2.8
1.7
—
—
—
0
0
45
586
0.74
1.13
1.4
1.2
7.14
1.13
u/ml
0.60
14
187
102
868
1.24
1.06
2.5
2.2
0.70
0.67
ug/l
0.17
67
470
9
46
1.98
1.04
1.8
1.2
—
—
—
0
0
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
268
2827
0.81
1.02
3.7
3.7
1.48
1.42
mmol/l
0.61
251
2665
9
50
1.82
0.97
1.8
1.3
—
1.12
—
0
7
0
31
0.00
0.97
0.0
1.4
—
350.00
—
0
5
9
51
1.78
0.95
1.8
1.3
9.56
11.00
g/l
—
9
42
6
27
2.24
0.94
1.5
1.0
—
—
—
0
0
36
271
1.36
0.93
12.8
10.7
0.51
1.32
mmol/l
0.73
29
221
15
94
1.62
0.92
5.5
9.5
1.87
1.64
%
0.20
15
88
6
28
2.16
0.92
3.7
2.7
—
—
—
0
0
6
28
2.16
0.92
2.5
4.3
—
—
—
0
0
19
127
1.52
0.90
1.9
1.8
64.52
67.73
g/l
1.00
19
113
6
29
2.09
0.89
1.0
1.0
—
—
—
0
0
8
42
1.92
0.89
1.0
1.7
—
—
—
0
0
20
136
1.50
0.88
2.8
2.1
0.59
0.62
%
0.21
20
136
6
30
2.02
0.87
1.2
1.5
—
—
—
0
0
6
31
1.95
0.84
2.7
2.1
105.17
105.42
mmol/l
—
6
31
6
31
1.95
0.84
1.0
1.1
—
—
—
0
0
6
32
1.89
0.82
1.2
1.5
—
—
—
0
0
6
32
1.89
0.82
1.0
1.1
—
—
—
0
0
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
12
74
1.64
0.79
1.2
1.1
—
—
—
0
0
12
75
1.62
0.76
1.2
1.1
—
—
—
0
0
5
24
2.10
0.75
1.0
1.1
—
—
—
0
0
37
292
1.30
0.73
3.6
4.2
30.04
29.31
%
0.15
28
222
102
901
1.18
0.72
4.0
2.4
202.66
164.25
ug/l
0.94
92
837
100
882
1.18
0.72
1.7
1.8
96.18
93.50
pmol/l
0.24
58
503
7
40
1.76
0.71
1.1
1.2
—
—
—
0
0
9
58
1.57
0.70
1.7
1.4
3.20
2.84
g/l
—
9
49
10
61
1.66
0.69
1.6
1.4
3.52
3.63
g/l
—
10
52
10
61
1.66
0.69
1.6
1.4
7.37
7.04
g/l
—
10
52
10
61
1.66
0.69
1.6
1.4
—
—
—
0
0
245
2572
0.86
0.68
6.1
5.2
39.60
39.89
mmol/mol
0.18
223
2442
5
27
1.86
0.68
1.0
1.1
257.60
280.32
mg/l
—
5
22
5
27
1.86
0.68
2.0
1.6
—
—
—
0
0
5
28
1.80
0.66
1.2
1.6
—
—
—
0
0
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
47
389
1.24
0.65
1.9
2.0
—
—
—
0
0
8
49
1.65
0.62
1.7
1.3
0.14
0.42
g/l
—
8
43
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
7
113
0.61
0.59
1.4
1.8
—
244.00
—
0
5
16
115
1.41
0.57
3.3
2.7
—
—
—
0
0
8
55
1.46
0.56
1.0
1.1
—
99.36
—
0
16
8
55
1.46
0.56
1.6
1.4
—
—
—
0
0
6
37
1.63
0.56
1.2
1.6
—
—
—
0
0
13
181
0.71
0.54
1.5
1.7
—
—
—
0
0
35
288
1.24
0.52
6.5
6.6
—
—
—
0
0
66
579
1.17
0.52
3.2
3.0
0.00
0.02
estimate
0.68
29
188
208
2185
0.89
0.50
3.2
3.1
54.50
49.05
u/l
0.34
197
2084
131
1211
1.13
0.49
3.0
3.0
22.76
23.61
%
0.26
57
437
7
46
1.53
0.48
1.9
1.2
36.03
38.99
g/l
—
7
37
50
431
1.19
0.48
1.9
2.1
—
—
—
0
0
11
77
1.44
0.46
1.1
1.3
—
—
—
0
0
5
84
0.59
0.46
1.0
1.0
—
3.42
—
0
13
62
698
0.87
0.45
1.8
1.7
1.55
1.56
mmol/l
0.06
48
600
5
31
1.62
0.43
1.2
1.5
—
—
—
0
0
52
457
1.16
0.41
1.5
1.4
18.46
19.21
nmol/l
0.15
46
394
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
6
42
1.44
0.35
1.0
1.1
—
—
—
0
0
11
82
1.35
0.34
1.1
1.8
—
—
—
0
0
7
54
1.30
0.30
1.3
1.1
—
—
—
0
0
51
464
1.12
0.26
1.6
1.8
403.55
9756509.20
pmol/l
0.50
40
410
9
72
1.26
0.26
1.0
1.2
—
—
—
0
0
9
73
1.24
0.25
1.1
1.6
—
—
—
0
0
13
105
1.25
0.25
3.1
3.6
22.58
24.98
mmol/l
1.43
13
99
213
2068
1.07
0.24
2.7
3.1
—
—
—
0
0
13
156
0.83
0.21
8.5
10.3
23.96
24.24
mmol/l
0.13
13
151
69
736
0.92
0.21
2.6
2.1
142.07
265.58
u/l
2.61
69
696
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
92
872
1.07
0.21
2.9
2.3
73.22
72.18
nmol/l
0.13
84
799
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
21
184
1.15
0.19
2.7
3.2
88.90
178.72
ng/l
1.50
21
164
228
2326
0.95
0.17
4.1
3.3
1.92
2.40
mu/l
0.45
204
2154
37
401
0.91
0.17
1.8
1.7
—
—
—
0
0
8
68
1.18
0.16
1.4
1.5
93.26
191.08
pmol/l
—
8
68
75
786
0.94
0.15
3.8
4.3
10.23
10.10
mg/mmol
0.01
50
550
12
103
1.17
0.14
3.8
2.7
—
—
—
0
0
51
538
0.94
0.12
3.1
3.2
1.02
1.02
kg/l
—
10
67
14
126
1.12
0.09
1.3
1.2
—
—
—
0
0
9
84
1.07
0.07
3.0
4.5
—
—
—
0
0
49
508
0.96
0.07
3.6
3.5
267.66
1026.92
ng/l
1.56
38
378
179
1774
1.02
0.04
3.6
2.7
15.02
14.89
pmol/l
0.26
162
1624
56
549
1.02
0.03
1.4
1.4
—
—
—
0
0
13
128
1.02
0.00
1.1
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
9
0.00
0.00
0.0
3.1
—
117.33
—
0
9
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
1.25
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
14.58
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
8
82
0.98
-0.00
2.9
2.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_TESTIS_SEMINOMA_WIDE – Seminoma of testis, including Hilmo
GWS hits: 2
This endpoint is excluded (different definition than used in FinnGen).